Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001437749-23-007564 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-22 | 2023-03-20 | BLFS | Wichterman Troy | CFO | M - OptEx | $2.06 | +938 | 78.2K | +1% | +$1,932 |
| DM | 2023-03-22 | 2023-03-20+ | BLFS | Wichterman Troy | CFO | S - Sale+OE | $20.68 | -10.3K | 68.2K | -13% | -$213.2K |
| D | 2023-03-22 | 2023-03-20 | BLFS | Wichterman Troy | CFO | M - OptEx | $0.00 | -938 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | M | A | 938 | $2.06 | 78,160 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-22 | S | D | 310 | $21.84 | 67,850 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-20 | S | D | 10,000 | $20.64 | 68,160 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $20.76, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Derivative | Stock Option | 2023-03-20 | M | D | 938 | $0.00 | 0 | D | $2.06 · — to 2025-05-04 | 938 Common Stock | (F1) The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 15, 2022. |